Lv1
70 积分 2023-12-01 加入
A Dual-Function LipoAraN-E5 Coloaded with N4-Myristyloxycarbonyl-1-β-d-arabinofuranosylcytosine (AraN) and a CXCR4 Antagonistic Peptide (E5) for Blocking the Dissemination of Acute Myeloid Leukemia
1个月前
已完结
Lipid nanoparticles for engineering next generation CAR T cell immunotherapy
4个月前
已完结
Multifaceted Pt Nanoclusters for Targeting Recognition, Cellular Uptake, and Therapy In Vivo and In Vitro in Chronic Myeloid Leukemia Cells
5个月前
已完结
Chemistry of Lipid Nanoparticles for RNA Delivery
5个月前
已完结
Lipid Nanoparticles Enabling Gene Therapies: From Concepts to Clinical Utility
5个月前
已完结
Size-Dependent In Vivo Transport of Nanoparticles: Implications for Delivery, Targeting, and Clearance
5个月前
已完结
Challenges and strategies in anti-cancer nanomedicine development: An industry perspective
5个月前
已完结
Advances of Nanoparticles for Leukemia Treatment
5个月前
已完结
Nanoparticle-Based Approaches for Treatment of Hematological Malignancies: a Comprehensive Review
5个月前
已完结
Use of polymeric CXCR4 inhibitors as siRNA delivery vehicles for the treatment of acute myeloid leukemia
5个月前
已完结
皖公网安备34019202002308
